269 related articles for article (PubMed ID: 37122726)
1. Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients.
Li S; Bai Y; Meng J; Wang Q; Tian X; Li M; Zeng X; Zhao J; Hu C
Front Immunol; 2023; 14():1107510. PubMed ID: 37122726
[TBL] [Abstract][Full Text] [Related]
2. Profile and clinical relevance of non-criteria antiphospholipid antibodies in patients diagnosed with or highly suspected of APS.
Li S; Zhao J; Bai Y; Meng J; Wang Q; Tian X; Li M; Zeng X; Hu C
Rheumatology (Oxford); 2024 Mar; 63(3):891-900. PubMed ID: 37382568
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of non-criteria antibodies to phospholipids in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Zhang W; Zhang F; Li Y; Liu Y
Clin Chim Acta; 2019 Aug; 495():205-209. PubMed ID: 31002781
[TBL] [Abstract][Full Text] [Related]
4. Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added.
Liu X; Zhu L; Liu H; Cai Q; Yun Z; Sun F; Jia Y; Guo J; Li C
Front Immunol; 2022; 13():972012. PubMed ID: 36389827
[TBL] [Abstract][Full Text] [Related]
5. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.
Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Zhou J; Norman GL; Wang X; Yang C; Shi H
Arthritis Res Ther; 2020 Feb; 22(1):33. PubMed ID: 32085759
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.
Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR
J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
[TBL] [Abstract][Full Text] [Related]
9. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity.
Akyüz Dağlı P; Erden A; Babaoğlu H; Karakaş Ö; Özdemir Ulusoy B; Konak HE; Armağan B; Erten Ş; Omma A
Ir J Med Sci; 2024 Apr; 193(2):1099-1107. PubMed ID: 37737913
[TBL] [Abstract][Full Text] [Related]
10. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.
Bertolaccini ML; Roch B; Amengual O; Atsumi T; Khamashta MA; Hughes GR
Br J Rheumatol; 1998 Nov; 37(11):1229-32. PubMed ID: 9851275
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort.
Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
Front Immunol; 2021; 12():741369. PubMed ID: 34567005
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
Radway-Bright EL; Ravirajan CT; Isenberg DA
Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
[TBL] [Abstract][Full Text] [Related]
13. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
14. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
15. Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China.
Zhou Y; Hu C; Qi W; Long Y; Huang C; Wang Q; Tian X; Zhao J; Li M; Zeng X
Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37607781
[TBL] [Abstract][Full Text] [Related]
16. [Value of IgA antiphospholipid antibodies in diagnosis of the antiphospholipid syndrome].
Yang B; Zhao JL; Huang ZC; Su ZZ; Li MT; Zeng XF; Hu CJ
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(41):3404-3410. PubMed ID: 34758544
[No Abstract] [Full Text] [Related]
17. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
18. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
Urrego-Callejas T; Hernández A; Ruiz Giraldo S; Frade-Sosa B; Vanegas-García AL; Muñoz CH; Rua C; Duque Botero J; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2023 Apr; 19(4):197-203. PubMed ID: 37061281
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to Domain I β
Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
[TBL] [Abstract][Full Text] [Related]
20. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
